Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non- Interventional Study to Observe Real Life Usage of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia.

NCT01544608 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01544608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01544608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non- Interventional Study to Observe Real Life Usage of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2012
Completion date
December 31, 2012
Enrollment
1,076 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia